Latest news
255 Canadian cancer patients share the most wasteful and inefficient parts of their cancer care and treatment
The Canadian All.Can cancer initiative has this month published a major report of cancer care recommendations based on patient insights following a Canada-wide patient survey conducted last year that gathered…
All.Can welcomes Roche as a new funding member
All.Can is delighted to welcome Roche as a new funding member of the international initiative.
All.Can Australia launches national data from patient survey
All.Can Australia has launched the results of the national-level findings from the All.Can international patient survey.
ICHOM–All.Can Improving Value in Cancer Care study discontinued
It is with great regret that All.Can has decided to discontinue the ICHOM–All.Can Improving Value in Cancer Care project.
All.Can Italy holds first public seminar on cancer networks
All.Can Italy held its first public seminar in Rome, bringing together patients, key opinion leaders and policymakers
International patient survey findings released in new report
Based on results of the All.Can patient survey, which was completed by almost 4,000 people affected by different cancers across 10 countries.
All.Can welcomes Baxter as a new contributor
All.Can is pleased to welcome Baxter as a new contributor to the international initiative.
All.Can at the ICHOM 2019 Conference
In May 2019 All.Can attended the International Consortium for Health Outcomes Measurement (ICHOM) Conference 2019, in Rotterdam.
All.Can at ICHOM Conference 2019
All.Can will be hosting a session at the International Consortium for Health Outcomes Measurement (ICHOM) Conference 2019, in Rotterdam on 2 May. The session, ‘All.Can and measuring the value…